hesperidin has been researched along with Allergic Encephalomyelitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aytac, B; Basak, N; Cetin, A; Ciftci, O; Kamisli, O; Ozcan, C | 1 |
| Haghmorad, D; Jalayer, Z; Kokhaei, P; Mahmoudi, M; Mahmoudi, MB; Momtazi Brojeni, AA; Rastin, M; Salehipour, Z | 1 |
2 other study(ies) available for hesperidin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Brain Chemistry; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Hesperidin; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Pertussis Toxin | 2015 |
Hesperidin ameliorates immunological outcome and reduces neuroinflammation in the mouse model of multiple sclerosis.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Hesperidin; Inflammation; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Spleen; Treatment Outcome | 2017 |